These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 18301313

  • 1. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
    Thomsen HS, Morcos SK, Erley CM, Grazioli L, Bonomo L, Ni Z, Romano L, Investigators in the Abdominal Computed Tomography: IOMERON 400 Versus VISIPAQUE 320 Enhancement (ACTIVE) Study.
    Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
    [Abstract] [Full Text] [Related]

  • 2. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
    Barrett BJ, Katzberg RW, Thomsen HS, Chen N, Sahani D, Soulez G, Heiken JP, Lepanto L, Ni ZH, Ni ZH, Nelson R.
    Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
    [Abstract] [Full Text] [Related]

  • 3. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, Gelormini JL, Labinaz M, Moreyra AE, Investigators of the CARE Study.
    Circulation; 2007 Jun 26; 115(25):3189-96. PubMed ID: 17562951
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography.
    Sahani DV, Soulez G, Chen KM, Lepanto L, Xu JR, Nelson RC, Grazioli L, Vanzulli A, Heiken JP, Investigators of the IMPACT Study.
    Invest Radiol; 2007 Dec 26; 42(12):856-61. PubMed ID: 18007158
    [Abstract] [Full Text] [Related]

  • 5. Enhancement and safety of iomeprol-400 and iodixanol-320 in patients undergoing abdominal multidetector CT.
    Romano L, Grazioli L, Bonomo L, Xu JR, Chen KM, Dore R, Vanzulli A, Catalano C.
    Br J Radiol; 2009 Mar 26; 82(975):204-11. PubMed ID: 19064592
    [Abstract] [Full Text] [Related]

  • 6. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure.
    Kuhn MJ, Chen N, Sahani DV, Reimer D, van Beek EJ, Heiken JP, So GJ.
    AJR Am J Roentgenol; 2008 Jul 26; 191(1):151-7. PubMed ID: 18562739
    [Abstract] [Full Text] [Related]

  • 7. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
    Shin DH, Choi DJ, Youn TJ, Yoon CH, Suh JW, Kim KI, Cho YS, Cho GY, Chae IH, Kim CH.
    Am J Cardiol; 2011 Jul 15; 108(2):189-94. PubMed ID: 21545991
    [Abstract] [Full Text] [Related]

  • 8. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B, Cheng WJ, Li YF, Cao Z, Yang Q, Zhao YX, Guo YH, Zhou YJ.
    Catheter Cardiovasc Interv; 2008 Dec 01; 72(7):958-65. PubMed ID: 19021282
    [Abstract] [Full Text] [Related]

  • 9. Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
    Laskey W, Aspelin P, Davidson C, Rudnick M, Aubry P, Kumar S, Gietzen F, Wiemer M, DXV405 Study Group.
    Am Heart J; 2009 Nov 01; 158(5):822-828.e3. PubMed ID: 19853704
    [Abstract] [Full Text] [Related]

  • 10. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
    Nguyen SA, Suranyi P, Ravenel JG, Randall PK, Romano PB, Strom KA, Costello P, Schoepf UJ.
    Radiology; 2008 Jul 01; 248(1):97-105. PubMed ID: 18483232
    [Abstract] [Full Text] [Related]

  • 11. Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography for patients with renal impairment.
    Becker CR, Reiser MF.
    Invest Radiol; 2005 Oct 01; 40(10):672-5. PubMed ID: 16189436
    [Abstract] [Full Text] [Related]

  • 12. Nephrotoxicity of iodixanol versus iopamidol in patients undergoing peripheral angiography with or without endovascular therapy.
    Xiong HL, Peng M, Jiang XJ, Dong H, Che WQ, Chen Y, Zou YB, Xu B, Yang YJ, Gao RL.
    Int Urol Nephrol; 2018 Oct 01; 50(10):1879-1886. PubMed ID: 29948863
    [Abstract] [Full Text] [Related]

  • 13. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH, Youn TJ, Koo BK, Park JS, Kang HJ, Cho YS, Chung WY, Joo GW, Chae IH, Choi DJ, Oh BH, Lee MM, Park YB, Kim HS.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):924-30. PubMed ID: 16949481
    [Abstract] [Full Text] [Related]

  • 14. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials.
    Thomsen HS, Morcos SK.
    Eur Radiol; 2009 Apr 05; 19(4):891-7. PubMed ID: 19002467
    [Abstract] [Full Text] [Related]

  • 15. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
    Juergens CP, Winter JP, Nguyen-Do P, Lo S, French JK, Hallani H, Fernandes C, Jepson N, Leung DY.
    Intern Med J; 2009 Jan 05; 39(1):25-31. PubMed ID: 18771430
    [Abstract] [Full Text] [Related]

  • 16. Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention.
    Wessely R, Koppara T, Bradaric C, Vorpahl M, Braun S, Schulz S, Mehilli J, Schömig A, Kastrati A, Contrast Media and Nephrotoxicity Following Coronary Revascularization by Angioplasty Trial Investigators.
    Circ Cardiovasc Interv; 2009 Oct 05; 2(5):430-7. PubMed ID: 20031753
    [Abstract] [Full Text] [Related]

  • 17. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
    Cheruvu B, Henning K, Mulligan J, Klippenstein D, Lawrence D, Gurtoo L, Gottlieb RH.
    J Comput Assist Tomogr; 2007 Oct 05; 31(4):493-8. PubMed ID: 17882021
    [Abstract] [Full Text] [Related]

  • 18. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
    Mehran R, Nikolsky E, Kirtane AJ, Caixeta A, Wong SC, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Kim YH, Fahy M, Dangas GD.
    JACC Cardiovasc Interv; 2009 May 05; 2(5):415-21. PubMed ID: 19463464
    [Abstract] [Full Text] [Related]

  • 19. MDCT angiography for detection of pulmonary emboli: comparison between equi-iodine doses of iomeprol 400 mgI/mL and iodixanol 320 mgI/mL.
    Langenberger H, Friedrich K, Plank C, Matzek W, Wolf F, Storto ML, Schaefer-Prokop C, Herold C.
    Eur J Radiol; 2009 Jun 05; 70(3):579-88. PubMed ID: 18384995
    [Abstract] [Full Text] [Related]

  • 20. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection.
    Schmid I, Didier D, Pfammatter T, Garachemani A, Fleisch M, Kirchin MA, Meier B.
    Int J Cardiol; 2007 Jun 12; 118(3):389-96. PubMed ID: 17376548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.